Rosacea - United States Market & Competitive Landscape (2018-2023) - ResearchAndMarkets.com

October 11, 2018

DUBLIN--(BUSINESS WIRE)--Oct 11, 2018--The “US Rosacea Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

This report provides comprehensive insights into Rosacea pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares.This study accurately estimates and forecast Rosacea market size and drug sales. This research also provides insights into Rosacea epidemiology and late stage pipeline.

The research is classified into following sections - Rosacea overview with definitions, symptoms, etiology, diagnosis, treatment options; Rosacea pipeline insights covering late stage clinical trials pipeline; Rosacea prevalence trends by countries; Rosacea market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.

Research Scope

Rosacea pipeline: Find out the drugs in clinical trials for Rosacea by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by companyRosacea epidemiology: Find out the prevalence of Rosacea in US; prevalence forecast to 2023Rosacea products: Identify key products marketed and prescribed for Rosacea by brand name, by molecule, by company, by branded / generic, in USRosacea market size: Find out the market size for Rosacea drugs in US; Find out how the market advanced from 2014Rosacea drug sales: Find out the sales of Rosacea drugs in USRosacea drugs sales forecast: Sales forecast for Rosacea drugs to 2023 in USRosacea market share analysis: Find out the market shares of Rosacea drugs and outlook in US

For more information about this report visit https://www.researchandmarkets.com/research/5kfv9j/rosacea_united?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181011005567/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Dermatological Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/11/2018 10:42 AM/DISC: 10/11/2018 10:42 AM


Update hourly